SOTYKTU® (deucravacitinib) is approved
SOTYKTU® (deucravacitinib) is approved Bristol Myers Squibb announced on March 6, 2026, that the U.S. Food and Drug Administration (FDA)...
Learn about financial options that may help your patients with LN
Support is available to help your patients with lupus nephritis start and stay on a prescribed Genentech medication. Genentech is...
HCPCS Coding Update from Organon Biosimilars
Permanent HCPCS Level II Coding for Organon’s biosimilars to PROLIA (denosumab) and XGEVA (denosumab) is now effective. Q-code: Q5162 Organon...
The Hidden Toll of PBM Practices on Rheumatology Care
The national conversation around Pharmacy Benefit Managers (PBMs) often centers on drug pricing. In rheumatology practices, however, the impact goes...
Winter Storm Preparation for Rheumatology Practices: Drugs, Staffing, and Office Readiness
Winter weather disruptions are becoming more frequent—and more unpredictable. For rheumatology practices, the impact goes far beyond delayed appointments. Weather-related...
Utilization of the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)
SLEDAI-2K is a Global Disease Index used to assess disease activity in patients with SLE.¹ There is an extensive range...
ACCESS AND REIMBURSEMENT GUIDE FOR SAPHNELO (anifrolumab-fnia)
The Access and Reimbursement Resource Guide offers resources to assist with the acquisition of products, including SAPHNELO, and features the...
Understanding the Importance of Billing Code G2211 in Rheumatology
In the ever-evolving landscape of healthcare, accurate billing and coding are crucial for ensuring that medical practices are reimbursed appropriately...
Decisions, decisions. Helping patients understand their RA treatment options
Information and resources for patients considering an autoinjector to manage the symptoms of rheumatoid arthritis (RA) Information and resources for...
NAMAPA Launches Medication Access Coordinator Training
The National Association for Medication Access and Patient Advocacy (NAMAPA) has launched the Medication Access Coordinator Training with the aim...
Change Healthcare Updates
The Change Healthcare cyber attack has been a big problem for the industry. NORM conducted a survey with our memebrship...
CMS released the CY 2024 PFS final rule
Per the CMS press release: Overall, the finalized CY 2024 PFS conversion factor is $32.74, a decrease of $.1.15, or 3.4%, from CY...
Contact
- As a speaker at the first ad hoc meeting of rheumatology practice managers gathered in a single small room at its infancy a decade ago, I’m amazed to see how NORM has blossomed into a high energy organization of depth and professional meetings with parallel break-out symposia between plenary sessions. NORM has truly come of age. This is where the “business” of rheumatology gets learned. The ”guildmanship” for rheumatology practice management is now strong.- Paul H. Caldron, DO, FACP, FACR, MBA, Arizona Arthritis and Rheumatology Associates
- In a time of demanding changes in the management of medical practices in the US, NORM has been a lifesaver to the community of Rheumatology practices. NORM has allowed our practice to stay ahead of the many demands of CMS and others payors and has ensured that our practice remains cognizant of new issues that arise in HIPPA compliance, human resources and medical billing to name a few. Sending our Practice Manager to NORM's conferences has been cost-effective and beneficial to our practice because she returns to our office with an abundance of information that otherwise would have taken months to compile. Every Rheumatology practice that wishes to stay on top of emerging issues in practice management should consider sending a member of their staff to NORM's conference.- Michael S. Rosen M.D., Chester County Rheumatology PC
- Thanks to all those wonderful people in the NORM Network who respond to emails, offering their advice, experience, time, and support ... I haven't even been a member a full year yet and I am amazed at the dedication of everyone who responds to helping via emails and the NORM Organization itself! I have barely had a chance to explore the resources and I have yet to really dive into requests for help still I am silently learning so much and do occasionally offer what I can! Thank you all!- Cheryl Piambino, Kenneth E. Bresky, DO
What We Offer
We’re adding value to practices across the nation by creating a thriving community of rheumatology managers and physicians.
Membership Benefits
Become a Member
Annual Conference
Conference Registration
